The present invention provides an animal model for monitoring Nipah virus
infection, a method for the quantitative detection and rapid
characterization of Nipah virus RNA in a sample, a composition which can
be used to provide immunoprotection in an individual as well as
monoclonal antibodies which neutralize Nipah and Hendra virus and can be
used for prophylaxis, treatment, and/or prevention.